Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies

被引：0
作者：
Margaret von Mehren
Michael Bookman
Neal J. Meropol
Louis M. Weiner
Eric Sherman
Jinhui Li
Roland Knoblauch
Trilok Parekh
Roger B. Cohen
机构：
[1] Fox Chase Cancer Center,Department of Medical Oncology
[2] US Oncology Research,Arizona Oncology
[3] University Hospitals Case Medical Center,Hematology and Oncology
[4] Seidman Cancer Center,undefined
[5] Georgetown University Medical Center,undefined
[6] Memorial Sloan-Kettering Cancer Center,undefined
[7] Janssen Research & Development,undefined
[8] LLC,undefined
[9] University of Pennsylvania,undefined
[10] Case Comprehensive Cancer Center,undefined
[11] Case Western Reserve University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Advanced malignancies; Combination chemotherapy; Docetaxel; Ovarian cancer; Sarcoma; Trabectedin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1047 / 1055
页数：8
相关论文
共 50 条
  • [1] Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies
    von Mehren, Margaret
    Bookman, Michael
    Meropol, Neal J.
    Weiner, Louis M.
    Sherman, Eric
    Li, Jinhui
    Knoblauch, Roland
    Parekh, Trilok
    Cohen, Roger B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 1047 - 1055
  • [2] A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
    von Mehren, M.
    Schilder, R. J.
    Cheng, J. D.
    Temmer, E.
    Cardoso, T. M.
    Renshaw, F. G.
    Bayever, E.
    Zannikos, P.
    Yuan, Z.
    Cohen, R. B.
    ANNALS OF ONCOLOGY, 2008, 19 (10) : 1802 - 1809
  • [3] Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
    Lia Gore
    E. Rivera
    M. Basche
    S. L. Moulder-Thompson
    J. Li
    S. Eppers
    S. Grolnic
    C. O’Bryant
    D. Cleere
    Y. A. Elsayed
    S. G. Eckhardt
    Investigational New Drugs, 2012, 30 : 1942 - 1949
  • [4] Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
    Gore, Lia
    Rivera, E.
    Basche, M.
    Moulder-Thompson, S. L.
    Li, J.
    Eppers, S.
    Grolnic, S.
    O'Bryant, C.
    Cleere, D.
    Elsayed, Y. A.
    Eckhardt, S. G.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1942 - 1949
  • [5] A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors
    Puglisi, Martina
    Molife, L. Rhoda
    de Jonge, Maja J. A.
    Khan, Khurum H.
    Doorn, Leni van
    Forster, Martin D.
    Blanco, Montserrat
    Gutierrez, Martin
    Franklin, Catherine
    Busman, Todd
    Yang, Jianning
    Eskens, Ferry A. L. M.
    FUTURE ONCOLOGY, 2021, 17 (21) : 2747 - 2758
  • [6] A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies
    Chow, Laura Q. M.
    Gustafson, Daniel L.
    O'Bryant, Cindy L.
    Gore, Lia
    Basche, Michele
    Holden, Scott N.
    Morrow, Mark C.
    Grolnic, Stacy
    Creese, Brian R.
    Roberts, Kaye L.
    Davis, Kat
    Addison, Russell
    Eckhardt, S. Gail
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 65 - 74
  • [7] A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies
    Laura Q. M. Chow
    Daniel L. Gustafson
    Cindy L. O’Bryant
    Lia Gore
    Michele Basche
    Scott N. Holden
    Mark C. Morrow
    Stacy Grolnic
    Brian R. Creese
    Kaye L. Roberts
    Kat Davis
    Russell Addison
    S. Gail Eckhardt
    Cancer Chemotherapy and Pharmacology, 2008, 63 : 65 - 74
  • [8] Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies
    Sunakawa, Yu
    Takahashi, Keishiro
    Kawaguchi, Osamu
    Yamamoto, Nobuyuki
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (05) : 1032 - 1041
  • [9] A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignancies
    Petit, T
    Aylesworth, C
    Burris, H
    Ravdin, P
    Rodriguez, G
    Smith, L
    Peacock, N
    Smetzer, L
    Bellet, R
    Von Hoff, DD
    Rowinsky, EK
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 223 - 229
  • [10] Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies
    Yu Sunakawa
    Keishiro Takahashi
    Osamu Kawaguchi
    Nobuyuki Yamamoto
    Investigational New Drugs, 2022, 40 : 1032 - 1041
12345